Unicyte AG

Switzerland
Oberdorf, Basel-Landschaft, Switzerland

Company profile

Unicyte AG company profile

Unicyte AG is a transformative regenerative medicine company advancing stem cell technologies into a novel class of human therapeutics. Unicyte has translated its ground-breaking discoveries into a broad pre-clinical pipeline in key therapeutic areas. The company evolved from a fifteen year research collaboration with Prof Giovanni Camussi, a leading expert on extracellular vesicles and stem cells from the University of Turin and Fresenius Medical Care KGaA, the world’s largest provider of products and services for individuals with renal diseases. Unicyte was founded in 2015 as an independent affiliate of Fresenius Medical Care and is headquartered in Oberdorf NW, Switzerland.

Business identity

Operating status
Active
Company type
For Profit
Employee range
51-100 employees
Revenue range
$1M-$10M
Founded
2015-01-01, Year

Headquarters

Country code
CH
Continent
Europe

Capital profile

Funding and company signals

No public funding data is available for this company.

Founders and investors

No public relation records are available.